Unfortunately, due to severe hepatic and cardiovascular side-effects, most TZDs were removed from the clinical use, with on pioglitazone still recommended by most guidelis as an anti-diabetic drug
Terrell JM, Jacobs TF (2024) Alogliptin Ahmed F, Ahmad SS, Alam MM, Khatoon A, Ali R, Ahmad J, Amina N, Najmi AK, Khan MA (2023) Hyperglycaemia induced osteoporosis: Is there a hope with dipeptidyl peptidase-4 inhibitors
Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study
False positives should be reconfirmed by consulting the doctor